Biostealth matrix for the future of precision medicine

Tetratherix has developed the first biostealth fluid matrix to disrupt regenerative medicine and targeted mRNA delivery

Tetratherix has developed a proprietary, fully synthetic biomaterial that is compatible with minimally invasive administration techniques and does not induce any foreign body reaction, a genuine biostealth platform technology. The company has active development programs in the areas of regenerative medicine and mRNA delivery. Our world-leading team has spent a decade, inventing and developing the biomaterial technology and has proven its safety and efficacy as the world’s first biostealth matrix.